Xione Therapeutics, Inc. — Form D
Xione Therapeutics, Inc. of HOUSTON, TX, a company, filed a Form D exempt-offering notice with the SEC on 2019-08-12. The offering totals $200K, of which $90K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2019-08-12
- Form: D
- Accession: 0001784593-19-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $200K
- Amount sold: $90K
- Remaining: $110K
- Investors: 4
- Date of first sale: 2019-06-05
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-346356
Issuer
- Name: Xione Therapeutics, Inc.
- CIK: 0001784593
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 2450 HOLCOMBE BOULEVARD., SUITE J, HOUSTON, TX, 77021
- Phone: 713-331-9443
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| Eric J Devroe | Director | Cambridge, MA |
| Eric J Devroe | Executive Officer | Cambridge, MA |
More